ANVISA Grants Commercial Approval to Concept Medical’s MagicTouch Sirolimus-Coated Balloon for CAD in Brazil
Revolutionary ANVISA Approval Advances Cardiovascular Treatment in Brazil with Concept Medical’s MagicTouch São Paulo (Brazil), September 17: Concept Medical Group, a global leader in drug-delivery technologies, announced that ANVISA (Agência Nacional de Vigilância Sanitária), Brazil’s Health Surveillance Agency, has granted commercial approval for its flagship MagicTouch, Sirolimus-Coated Balloon (SCB) for CAD treatment. This milestone enables patients […]
Continue Reading